RxDoctor Payments Data

Yauhen Tarbunou, MD

Vascular Surgery · St. Cloud, MNNPI 1265721757

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (59.4%), food and beverage and grants — rather than concentrated in one kind of arrangement. Medtronic accounts for 69.5% of it on its own, with 7 other manufacturers making up the rest. Among vascular surgery clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,019in general payments, 2019–2025

Across 174 payments — averaging $149.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$18K
  • Terumo Medical Corporation$4K
  • W. L. Gore & Associates, Inc.$3K
  • Silk Road Medical, Inc.$372
  • Philips North America LLC$339
  • Bard Peripheral Vascular, Inc.$132
  • plus $48 from 2 others

What the payments were for

  • Grants$4,00015%
  • Travel & lodging$15,46259%
  • Food & beverage$6,55825%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,019 in reported general payments places this provider in the 90th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$91,237
Medicare patients
297
Services billed
718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban21$18,152
Cilostazol76$1,761
Atorvastatin Calcium103$1,599
ClopidogrelClopidogrel Bisulfate79$1,309
Rosuvastatin Calcium29$624
Methylprednisolone13$93
Oxycodone Hcl24$67

Paid to pharmacies, not to this prescriber.

Other vascular surgery in St. Cloud

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →